Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

Identifieur interne : 001F23 ( Ncbi/Merge ); précédent : 001F22; suivant : 001F24

SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

Auteurs : G. Y. Oudit ; Z. Kassiri ; C. Jiang ; P. P. Liu ; S. M. Poutanen ; J. M. Penninger ; J. Butany

Source :

RBID : PMC:7163766

Descripteurs français

English descriptors

Abstract

Abstract

Background  Angiotensin converting enzyme 2 (ACE2), a monocarboxylase that degrades angiotensin II to angiotensin 1–7, is also the functional receptor for severe acute respiratory syndrome (SARS) coronavirus (SARS‐CoV) and is highly expressed in the lungs and heart. Patients with SARS also suffered from cardiac disease including arrhythmias, sudden cardiac death, and systolic and diastolic dysfunction.

Materials and methods  We studied mice infected with the human strain of the SARS‐CoV and encephalomyocarditis virus and examined ACE2 mRNA and protein expression. Autopsy heart samples from patients who succumbed to the SARS crisis in Toronto (Canada) were used to investigate the impact of SARS on myocardial structure, inflammation and ACE2 protein expression.

Results  Pulmonary infection with the human SARS‐CoV in mice led to an ACE2‐dependent myocardial infection with a marked decrease in ACE2 expression confirming a critical role of ACE2 in mediating SARS‐CoV infection in the heart. The SARS‐CoV viral RNA was detected in 35% (7/20) of autopsied human heart samples obtained from patients who succumbed to the SARS crisis during the Toronto SARS outbreak. Macrophage‐specific staining showed a marked increase in macrophage infiltration with evidence of myocardial damage in patients who had SARS‐CoV in their hearts. The presence of SARS‐CoV in the heart was also associated with marked reductions in ACE2 protein expression.

Conclusions  Our data show that SARS‐CoV can mediate myocardial inflammation and damage associated with down‐regulation of myocardial ACE2 system, which may be responsible for the myocardial dysfunction and adverse cardiac outcomes in patients with SARS.


Url:
DOI: 10.1111/j.1365-2362.2009.02153.x
PubMed: 19453650
PubMed Central: 7163766

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:7163766

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS</title>
<author>
<name sortKey="Oudit, G Y" sort="Oudit, G Y" uniqKey="Oudit G" first="G. Y." last="Oudit">G. Y. Oudit</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kassiri, Z" sort="Kassiri, Z" uniqKey="Kassiri Z" first="Z." last="Kassiri">Z. Kassiri</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jiang, C" sort="Jiang, C" uniqKey="Jiang C" first="C." last="Jiang">C. Jiang</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liu, P P" sort="Liu, P P" uniqKey="Liu P" first="P. P." last="Liu">P. P. Liu</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Poutanen, S M" sort="Poutanen, S M" uniqKey="Poutanen S" first="S. M." last="Poutanen">S. M. Poutanen</name>
<affiliation>
<nlm:aff id="a4"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Penninger, J M" sort="Penninger, J M" uniqKey="Penninger J" first="J. M." last="Penninger">J. M. Penninger</name>
<affiliation>
<nlm:aff id="a5"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Butany, J" sort="Butany, J" uniqKey="Butany J" first="J." last="Butany">J. Butany</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">19453650</idno>
<idno type="pmc">7163766</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163766</idno>
<idno type="RBID">PMC:7163766</idno>
<idno type="doi">10.1111/j.1365-2362.2009.02153.x</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">000872</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000872</idno>
<idno type="wicri:Area/Pmc/Curation">000872</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000872</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000C72</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C72</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19453650</idno>
<idno type="wicri:Area/PubMed/Corpus">001896</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001896</idno>
<idno type="wicri:Area/PubMed/Curation">001896</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001896</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001794</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001794</idno>
<idno type="wicri:Area/Ncbi/Merge">001F23</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS</title>
<author>
<name sortKey="Oudit, G Y" sort="Oudit, G Y" uniqKey="Oudit G" first="G. Y." last="Oudit">G. Y. Oudit</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kassiri, Z" sort="Kassiri, Z" uniqKey="Kassiri Z" first="Z." last="Kassiri">Z. Kassiri</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jiang, C" sort="Jiang, C" uniqKey="Jiang C" first="C." last="Jiang">C. Jiang</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liu, P P" sort="Liu, P P" uniqKey="Liu P" first="P. P." last="Liu">P. P. Liu</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Poutanen, S M" sort="Poutanen, S M" uniqKey="Poutanen S" first="S. M." last="Poutanen">S. M. Poutanen</name>
<affiliation>
<nlm:aff id="a4"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Penninger, J M" sort="Penninger, J M" uniqKey="Penninger J" first="J. M." last="Penninger">J. M. Penninger</name>
<affiliation>
<nlm:aff id="a5"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Butany, J" sort="Butany, J" uniqKey="Butany J" first="J." last="Butany">J. Butany</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">European Journal of Clinical Investigation</title>
<idno type="ISSN">0014-2972</idno>
<idno type="eISSN">1365-2362</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autopsy</term>
<term>Cardiovascular Diseases (prevention & control)</term>
<term>Cardiovascular Diseases (virology)</term>
<term>Down-Regulation</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Mice</term>
<term>Myocardium (pathology)</term>
<term>Peptidyl-Dipeptidase A (genetics)</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (metabolism)</term>
<term>Virus Activation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activation virale</term>
<term>Animaux</term>
<term>Autopsie</term>
<term>Humains</term>
<term>Immunohistochimie</term>
<term>Maladies cardiovasculaires ()</term>
<term>Maladies cardiovasculaires (virologie)</term>
<term>Myocarde (anatomopathologie)</term>
<term>Mâle</term>
<term>Peptidyl-Dipeptidase A (génétique)</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Régulation négative</term>
<term>Souris</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Myocarde</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Peptidyl-Dipeptidase A</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Peptidyl-Dipeptidase A</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Myocardium</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Maladies cardiovasculaires</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Autopsy</term>
<term>Down-Regulation</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Mice</term>
<term>Virus Activation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activation virale</term>
<term>Animaux</term>
<term>Autopsie</term>
<term>Humains</term>
<term>Immunohistochimie</term>
<term>Maladies cardiovasculaires</term>
<term>Mâle</term>
<term>Régulation négative</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>
<bold>Background </bold>
Angiotensin converting enzyme 2 (ACE2), a monocarboxylase that degrades angiotensin II to angiotensin 1–7, is also the functional receptor for severe acute respiratory syndrome (SARS) coronavirus (SARS‐CoV) and is highly expressed in the lungs and heart. Patients with SARS also suffered from cardiac disease including arrhythmias, sudden cardiac death, and systolic and diastolic dysfunction.</p>
<p>
<bold>Materials and methods </bold>
We studied mice infected with the human strain of the SARS‐CoV and encephalomyocarditis virus and examined ACE2 mRNA and protein expression. Autopsy heart samples from patients who succumbed to the SARS crisis in Toronto (Canada) were used to investigate the impact of SARS on myocardial structure, inflammation and ACE2 protein expression.</p>
<p>
<bold>Results </bold>
Pulmonary infection with the human SARS‐CoV in mice led to an ACE2‐dependent myocardial infection with a marked decrease in ACE2 expression confirming a critical role of ACE2 in mediating SARS‐CoV infection in the heart. The SARS‐CoV viral RNA was detected in 35% (7/20) of autopsied human heart samples obtained from patients who succumbed to the SARS crisis during the Toronto SARS outbreak. Macrophage‐specific staining showed a marked increase in macrophage infiltration with evidence of myocardial damage in patients who had SARS‐CoV in their hearts. The presence of SARS‐CoV in the heart was also associated with marked reductions in ACE2 protein expression.</p>
<p>
<bold>Conclusions </bold>
Our data show that SARS‐CoV can mediate myocardial inflammation and damage associated with down‐regulation of myocardial ACE2 system, which may be responsible for the myocardial dysfunction and adverse cardiac outcomes in patients with SARS.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<double pmid="19453650">
<pmc>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS</title>
<author>
<name sortKey="Oudit, G Y" sort="Oudit, G Y" uniqKey="Oudit G" first="G. Y." last="Oudit">G. Y. Oudit</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kassiri, Z" sort="Kassiri, Z" uniqKey="Kassiri Z" first="Z." last="Kassiri">Z. Kassiri</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jiang, C" sort="Jiang, C" uniqKey="Jiang C" first="C." last="Jiang">C. Jiang</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liu, P P" sort="Liu, P P" uniqKey="Liu P" first="P. P." last="Liu">P. P. Liu</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Poutanen, S M" sort="Poutanen, S M" uniqKey="Poutanen S" first="S. M." last="Poutanen">S. M. Poutanen</name>
<affiliation>
<nlm:aff id="a4"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Penninger, J M" sort="Penninger, J M" uniqKey="Penninger J" first="J. M." last="Penninger">J. M. Penninger</name>
<affiliation>
<nlm:aff id="a5"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Butany, J" sort="Butany, J" uniqKey="Butany J" first="J." last="Butany">J. Butany</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">19453650</idno>
<idno type="pmc">7163766</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163766</idno>
<idno type="RBID">PMC:7163766</idno>
<idno type="doi">10.1111/j.1365-2362.2009.02153.x</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">000872</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000872</idno>
<idno type="wicri:Area/Pmc/Curation">000872</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000872</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000C72</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C72</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS</title>
<author>
<name sortKey="Oudit, G Y" sort="Oudit, G Y" uniqKey="Oudit G" first="G. Y." last="Oudit">G. Y. Oudit</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kassiri, Z" sort="Kassiri, Z" uniqKey="Kassiri Z" first="Z." last="Kassiri">Z. Kassiri</name>
<affiliation>
<nlm:aff id="a1"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jiang, C" sort="Jiang, C" uniqKey="Jiang C" first="C." last="Jiang">C. Jiang</name>
<affiliation>
<nlm:aff id="a2"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liu, P P" sort="Liu, P P" uniqKey="Liu P" first="P. P." last="Liu">P. P. Liu</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Poutanen, S M" sort="Poutanen, S M" uniqKey="Poutanen S" first="S. M." last="Poutanen">S. M. Poutanen</name>
<affiliation>
<nlm:aff id="a4"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Penninger, J M" sort="Penninger, J M" uniqKey="Penninger J" first="J. M." last="Penninger">J. M. Penninger</name>
<affiliation>
<nlm:aff id="a5"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Butany, J" sort="Butany, J" uniqKey="Butany J" first="J." last="Butany">J. Butany</name>
<affiliation>
<nlm:aff id="a3"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">European Journal of Clinical Investigation</title>
<idno type="ISSN">0014-2972</idno>
<idno type="eISSN">1365-2362</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<title>Abstract</title>
<p>
<bold>Background </bold>
Angiotensin converting enzyme 2 (ACE2), a monocarboxylase that degrades angiotensin II to angiotensin 1–7, is also the functional receptor for severe acute respiratory syndrome (SARS) coronavirus (SARS‐CoV) and is highly expressed in the lungs and heart. Patients with SARS also suffered from cardiac disease including arrhythmias, sudden cardiac death, and systolic and diastolic dysfunction.</p>
<p>
<bold>Materials and methods </bold>
We studied mice infected with the human strain of the SARS‐CoV and encephalomyocarditis virus and examined ACE2 mRNA and protein expression. Autopsy heart samples from patients who succumbed to the SARS crisis in Toronto (Canada) were used to investigate the impact of SARS on myocardial structure, inflammation and ACE2 protein expression.</p>
<p>
<bold>Results </bold>
Pulmonary infection with the human SARS‐CoV in mice led to an ACE2‐dependent myocardial infection with a marked decrease in ACE2 expression confirming a critical role of ACE2 in mediating SARS‐CoV infection in the heart. The SARS‐CoV viral RNA was detected in 35% (7/20) of autopsied human heart samples obtained from patients who succumbed to the SARS crisis during the Toronto SARS outbreak. Macrophage‐specific staining showed a marked increase in macrophage infiltration with evidence of myocardial damage in patients who had SARS‐CoV in their hearts. The presence of SARS‐CoV in the heart was also associated with marked reductions in ACE2 protein expression.</p>
<p>
<bold>Conclusions </bold>
Our data show that SARS‐CoV can mediate myocardial inflammation and damage associated with down‐regulation of myocardial ACE2 system, which may be responsible for the myocardial dysfunction and adverse cardiac outcomes in patients with SARS.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</pmc>
<pubmed>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.</title>
<author>
<name sortKey="Oudit, G Y" sort="Oudit, G Y" uniqKey="Oudit G" first="G Y" last="Oudit">G Y Oudit</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. gavin.oudit@ualberta.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kassiri, Z" sort="Kassiri, Z" uniqKey="Kassiri Z" first="Z" last="Kassiri">Z. Kassiri</name>
</author>
<author>
<name sortKey="Jiang, C" sort="Jiang, C" uniqKey="Jiang C" first="C" last="Jiang">C. Jiang</name>
</author>
<author>
<name sortKey="Liu, P P" sort="Liu, P P" uniqKey="Liu P" first="P P" last="Liu">P P Liu</name>
</author>
<author>
<name sortKey="Poutanen, S M" sort="Poutanen, S M" uniqKey="Poutanen S" first="S M" last="Poutanen">S M Poutanen</name>
</author>
<author>
<name sortKey="Penninger, J M" sort="Penninger, J M" uniqKey="Penninger J" first="J M" last="Penninger">J M Penninger</name>
</author>
<author>
<name sortKey="Butany, J" sort="Butany, J" uniqKey="Butany J" first="J" last="Butany">J. Butany</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19453650</idno>
<idno type="pmid">19453650</idno>
<idno type="doi">10.1111/j.1365-2362.2009.02153.x</idno>
<idno type="wicri:Area/PubMed/Corpus">001896</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001896</idno>
<idno type="wicri:Area/PubMed/Curation">001896</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001896</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001794</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001794</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.</title>
<author>
<name sortKey="Oudit, G Y" sort="Oudit, G Y" uniqKey="Oudit G" first="G Y" last="Oudit">G Y Oudit</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. gavin.oudit@ualberta.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kassiri, Z" sort="Kassiri, Z" uniqKey="Kassiri Z" first="Z" last="Kassiri">Z. Kassiri</name>
</author>
<author>
<name sortKey="Jiang, C" sort="Jiang, C" uniqKey="Jiang C" first="C" last="Jiang">C. Jiang</name>
</author>
<author>
<name sortKey="Liu, P P" sort="Liu, P P" uniqKey="Liu P" first="P P" last="Liu">P P Liu</name>
</author>
<author>
<name sortKey="Poutanen, S M" sort="Poutanen, S M" uniqKey="Poutanen S" first="S M" last="Poutanen">S M Poutanen</name>
</author>
<author>
<name sortKey="Penninger, J M" sort="Penninger, J M" uniqKey="Penninger J" first="J M" last="Penninger">J M Penninger</name>
</author>
<author>
<name sortKey="Butany, J" sort="Butany, J" uniqKey="Butany J" first="J" last="Butany">J. Butany</name>
</author>
</analytic>
<series>
<title level="j">European journal of clinical investigation</title>
<idno type="eISSN">1365-2362</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autopsy</term>
<term>Cardiovascular Diseases (prevention & control)</term>
<term>Cardiovascular Diseases (virology)</term>
<term>Down-Regulation</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Mice</term>
<term>Myocardium (pathology)</term>
<term>Peptidyl-Dipeptidase A (genetics)</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (metabolism)</term>
<term>Virus Activation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activation virale</term>
<term>Animaux</term>
<term>Autopsie</term>
<term>Humains</term>
<term>Immunohistochimie</term>
<term>Maladies cardiovasculaires ()</term>
<term>Maladies cardiovasculaires (virologie)</term>
<term>Myocarde (anatomopathologie)</term>
<term>Mâle</term>
<term>Peptidyl-Dipeptidase A (génétique)</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Régulation négative</term>
<term>Souris</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Myocarde</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Peptidyl-Dipeptidase A</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Peptidyl-Dipeptidase A</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Myocardium</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Maladies cardiovasculaires</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Cardiovascular Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Autopsy</term>
<term>Down-Regulation</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Mice</term>
<term>Virus Activation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activation virale</term>
<term>Animaux</term>
<term>Autopsie</term>
<term>Humains</term>
<term>Immunohistochimie</term>
<term>Maladies cardiovasculaires</term>
<term>Mâle</term>
<term>Régulation négative</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Angiotensin converting enzyme 2 (ACE2), a monocarboxylase that degrades angiotensin II to angiotensin 1-7, is also the functional receptor for severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) and is highly expressed in the lungs and heart. Patients with SARS also suffered from cardiac disease including arrhythmias, sudden cardiac death, and systolic and diastolic dysfunction.</div>
</front>
</TEI>
</pubmed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F23 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001F23 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     PMC:7163766
   |texte=   SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:19453650" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021